Brammer Bio Overview
- Founded
- 2006
- Status
- Acquired/Merged
- Employees
- 600
- Latest Deal Type
- M&A
- Financing Rounds
- 2
- Investments
- 1
Brammer Bio General Information
Description
Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides clinical and commercial development, manufacturing supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with the process and analytical development, and regulatory support, enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.
Contact Information
Website
www.brammerbio.com
Formerly Known As
Florida Biologix
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
- 250 Binney Street
- Cambridge, MA 02142
- United States
+1 (866) 000-0000
Brammer Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Brammer Bio‘s full profile, request access.
Request a free trialBrammer Bio Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides cli
Biotechnology
Cambridge, MA
600
As of 2019
0.000
0000-00-00
000000&0
00000000
sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000000000000
San Francisco, CA
000
As of 0000
00000
0.000
0000-00-00
000000&0
00000
0000000
it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
Cambridge, MA
0000
As of 0000
00.000
000000000
00.000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialBrammer Bio Competitors (39)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Principia Biopharma | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
| 0000000 | Formerly PE-Backed | Cambridge, MA | 0000 | 00.000 | 000000000 | 00.000 |
| 0000000 000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 000000000000 | 0000 |
| 0000000 0000000000 | Venture Capital-Backed | Maastricht, Netherlands | 00 | 000.00 | 0000000000 | 000.00 |
| 0000000 0000000000 | Accelerator/Incubator Backed | Alachua, FL | 00000 | 000000000000 | 00000 |
Brammer Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBrammer Bio Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Brammer Bio‘s full profile, request access.
Request a free trialBrammer Bio Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 31-Mar-2016 | 0000000000 | Biotechnology | 0000000 0 |